Latest news
Loading news…
Thymmune Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2019 11-50 employees For Profit
Thymmune Therapeutics develops cell-based immunotherapies focused on restoring immune function through thymic cell engineering.
Thymmune Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Thymmune Therapeutics was acquired by United Therapeutics in 2026 for $140M.
Total Funding
$7M
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
9
Patents
4
About Thymmune Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $405.23K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 21
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jul 2, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 9.6
- Trend (90d)
- 9.5
Thymmune Therapeutics Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
Thymmune Therapeutics Key People
CEO and Founder
CSO
9
professional contacts at Thymmune Therapeutics
Contact execs at Thymmune Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Thymmune Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.